MSC-EVs decrease epithelial cell inflammation and improve cell health. by Caryn Cloer (351721)

RNS60 treatment decreased Aß aggregation and neurodegeneration in the stratum pyramidale in the CA3 region of the hippocampus of tMCAo animals 14 days after stroke. by Gloria Patricia Baena-Caldas (17721328)

Table1_Satisfaction With Governmental Risk Communication Both Increases and Decreases COVID-19 Mitigation Behaviours.docx by Darrick Evensen (13757068)

“…</p><p>Results: Structural equation modelling reveals that whilst perceptions of effective risk communication directly increase behaviours that mitigate COVID-19 health risks, these same perceptions indirectly decrease behaviour frequency via a mediated relationship with societal risk perceptions.…”

Decreased platelet responsiveness to clopidogrel correlates with CYP2C19 and PON1 polymorphisms in atherosclerotic patients by J.F.M. Marchini (6515189)

<i>Mycobacterium tuberculosis</i> thymidylate synthase (ThyX) is a target for plumbagin, a natural product with antimycobacterial activity - Fig 2 by Apurba Sarkar (8399571)

Workplace prevalence trajectories in the “University” case study, where workplace transmission can decrease as a result of mitigations introduced upon an increase in prevalence.... by Sarah F. Poole (11268956)

Fig6B_modifiedSplitter_adjustTidalVolume_Patients_C_C_decrease: Variables for pair C-C, where the Tidal Volume of one patient was decreased by 30% whilst maintaining the other patient constant. from A simulated single ventilator/dual patient ventilation strategy for acute respiratory distress syndrome during the COVID-19 pandemic by José A. Solís-Lemus (9272948)

Mean CBD concentration (%) for duration of vegetative phase (DVP) and inflorescence fraction. by Torsten Schober (20485754)

Scatterplot of the incidence rate of tuberculosis (TB) in 1990 versus (a) the cumulative mortality rate of COVID-19 and (b) the cumulative incidence rate of COVID-19 on 5 April 202... by Kazuo Inoue (302545)

Scatterplot of the mortality rate of tuberculosis (TB) in 1950 versus (a) cumulative mortality rate of COVID-19 and (b) the cumulative incidence rate of COVID-19 on 5 April 2020, a... by Kazuo Inoue (302545)

Adjusted prevalences (aP) by age, sex and altitude. by Juan Alonso Leon-Abarca (8308005)

Data_Sheet_1_Thrombotic Events in COVID-19 Are Associated With a Lower Use of Prophylactic Anticoagulation Before Hospitalization and Followed by Decreases in Platelet Reactivity.docx by Chantal C. Clark (10684632)

“…</p><p>Conclusion: We observed an association between the use of preexisting thromboprophylaxis and a decreased risk of TE during COVID-19. This suggests that these therapies are beneficial for coping with COVID-19 associated hypercoagulability. …”

Determinants of decrease in COVID-19 immunity among vaccinated patients over a 6-month period using univariate analysis and multivariable logistic regression models. by Dalal Nour (18530615)

“…<p>Determinants of decrease in COVID-19 immunity among vaccinated patients over a 6-month period using univariate analysis and multivariable logistic regression models.…”

Root-mean-square fluctuation (RMSF) analysis of wild-type and p.R163C mutant αB-crystallin dimers from molecular dynamics simulations. by Aref Baharvand (21713886)

Projection of testing costs under different cost scenarios for medical supplies and personnel (USD). by Nelmo Jordão Manjate (16324619)

Subjects:

Summary of resources per type of test and costs for Ag-RDT tests (USD 2020). by Nelmo Jordão Manjate (16324619)

Subjects:

Unit cost per test type and per health facility for diagnosis of SARS-CoV-2 by Ag-RDT and RT-PCR. by Nelmo Jordão Manjate (16324619)

Subjects:

S1 Dataset - by Nelmo Jordão Manjate (16324619)

Subjects:

Average value of cost components composing the unit cost (in USD) of SARS-CoV-2 diagnosis per per device type. by Nelmo Jordão Manjate (16324619)

Subjects:

Decrease of HLA-DR expression is more pronounced in severe cases. by Sanja Matic (9931091)